In Su Hwang

Title: In Su Hwang: Innovator in Intracellular Delivery Systems

Introduction

In Su Hwang is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of innovative methods for intracellular delivery systems. His work focuses on utilizing human-derived proteins to enhance the efficiency of delivering various materials into cells.

Latest Patents

In Su Hwang holds a patent for a transmembrane domain derived from the human LRRC24 protein. This invention, known as the LRRC24P transmembrane domain, provides a novel approach to intracellular delivery. The transmembrane domain can effectively transport cargo materials, including compounds, biomolecules, and various polymer materials, into cells. Notably, the LRRC24P transmembrane domain exhibits higher cell penetration efficiency compared to conventional cell-penetrating peptides. Additionally, since it is derived from human proteins, it minimizes the risk of side effects and immune responses associated with foreign protein-derived peptides.

Career Highlights

In Su Hwang is affiliated with the Korea Research Institute of Chemical Technology, where he continues to advance his research in biotechnology. His innovative work has positioned him as a key figure in the development of effective intracellular delivery methods.

Collaborations

In his professional journey, In Su Hwang has collaborated with notable colleagues, including Seong Jun Kim and Kyun Do Kim. These collaborations have further enriched his research and contributed to the advancement of their shared goals in the field.

Conclusion

In Su Hwang's contributions to the field of biotechnology, particularly through his patented transmembrane domain, highlight his role as an innovator in intracellular delivery systems. His work promises to enhance the effectiveness of delivering therapeutic materials into human cells, paving the way for future advancements in medical applications.